Ingrid Rulifson

About Ingrid Rulifson

Scientist• 30+ years of hands-on in vitro and in vivo research experience in several biology and disease-indication areas and innovative technology development; 19+ years of experience in early discovery drug development• Broad expertise in harnessing internal and external resources and developing creative and robust platforms to identify and prosecute novel human therapeutic targets efficiently and with translatable value • Skilled navigator of dynamic, matrixed environments, and manager of cross-functional teams and independent researchers • Proficient at multi-tasking, able to clearly identify and communicate goals and data, orally and written, to team members and upper management on both high and detailed levels.• Effective collaborator with a history of building enthusiastic teams committed to high scientific standards, clear constructive communication, and timely delivery of results

Experience

1. Scientific Associate Director

   Amgen

   Jul 2023 — Present

   Program and Research Lead, People Manager, Postdoctoral Fellow Advisor, and Cross-Functional Team Member in Discovery Research• Therapeutic focus areas primarily include Cardiovascular diseases, Heart Failure, Non-Alcoholic Fatty Liver Disease, and Diabetes• Develop innovative, multi-modality pre-discovery platforms and programs; identify, validate and characterize novel therapeutic targets; design, lead, and/or manage both low and high-throughput target screening and optimization, develop in vivo models, run preclinical efficacy studies, and drive mechanism of action/biology research; advance clinical candidates through the R&D pipeline• Expertise in developing an siRNA therapeutic from conception into the clinic, including developing in vitro and in vivo screening and optimization models, developing preclinical efficacy models, and authoring of IND reports, patents, and publications• Broad experience partnering with numerous academic and external industry collaborators, including business development opportunities, to build, evaluate, implement products, technology and platforms, and drive discovery research programs • Amgen Ambassador to Stanford University: build relationships, expand outreach, and develop collaborations with students, faculty, and staff• Volunteer for Amgen Biotech Experience (ABE)• Mentor for SMDP (Scientific Mentoring & Diversity Program)2024 and 2021 Amgen Research Recognition Award Recipient for Rapid Progression of Pipeline Programs 2020 and 2019 Amgen Research Recognition Award Recipient for Innovation2023 Amgen Research Recognition Award Recipient for Collaboration2022 Amgen 3R Award Recipient

Education

• University of Chicago

  Ph.D., Immunology

  1994 — 2000

• University of California, Santa Cruz

  BA, Psychology/Biology

  1986 — 1991

• Stanford University School of Medicine

  Postdoctoral Fellow, Pancreas Biology

  2001 — 2005

• University of California, San Francisco - School of Medicine

  Postdoctoral Fellow, Immunology/Pancreas Biology

  2000 — 2001

Skills

• Immunohistochemistry
• Confocal Microscopy
• Drug Development
• Drug Discovery
• Molecular Biology
• Fluorescence Microscopy
• Immunology
• Assay Development
• Biotechnology
• Stem Cells
• In Vivo
• Histology
• Cell Biology
• Cell Culture
• In Vitro
• Antibodies
• Diabetes
• Elisa
• Animal Models
• Science
• Lifesciences
• Biomarker Discovery
• Genomics